# Nevada Health Centers, Inc.

Health Center, NV
Page: https://astrelis.co/providers/health_center/291802  
This twin: https://astrelis.co/providers/health_center/291802.md  
CMS Certification Number (CCN): 291802  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2019 to 2025)

- **Total patients (UDS) (FY2024):** 45,860. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2025):** -127.2%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 28. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 27.3%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2025):** $28.6M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2025):** -4.2%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### Nevada Health Centers, Inc., NV

Match to this profile: matched by name (method: name and state).

- FY ending 2025-05-31 (audit year 2025): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2025-05-GSAFAC-0000377533
- FY ending 2024-05-31 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-05-GSAFAC-0000051073
- FY ending 2023-05-31 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-05-GSAFAC-0000003721

| Line | FY ending 2025-05-31 | FY ending 2024-05-31 | FY ending 2023-05-31 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 11,194,073 [derived, p.6] | 16,095,394 [derived, p.6] | 15,391,981 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 2,899,985 [derived, p.6] | 4,750,907 [derived, p.6] | 2,515,403 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 2,264,258 [derived, p.6] | 3,318,311 [derived, p.6] | 10,620,317 [derived, p.6] |
| other current assets (Statement of financial position) | 930,961 [derived, p.6] | 1,013,562 [derived, p.6] | 1,145,774 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 17,289,277 [extracted, p.6] | 25,178,174 [extracted, p.6] | 29,673,475 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 24,871,463 [derived, p.6] | 23,823,696 [derived, p.6] | 22,830,191 [derived, p.6] |
| other long-term assets (Statement of financial position) | 5,106,205 [derived, p.6] | 3,817,134 [derived, p.6] | 3,982,647 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 47,266,945 [extracted, p.6] | 52,819,004 [extracted, p.6] | 56,486,313 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 4,864,234 [derived, p.6] | 4,768,773 [derived, p.6] | 5,337,250 [derived, p.6] |
| deferred revenue (Statement of financial position) | 429,163 [derived, p.6] | 719,422 [derived, p.6] | 979,672 [derived, p.6] |
| current debt and leases (Statement of financial position) | 1,123,934 [derived, p.6] | 742,889 [derived, p.6] | 1,439,356 [derived, p.6] |
| other current liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 6,417,331 [extracted, p.6] | 6,231,084 [extracted, p.6] | 7,756,278 [extracted, p.6] |
| long-term debt and leases (Statement of financial position) | 4,563,825 [derived, p.6] | 3,610,813 [derived, p.6] | 3,855,214 [derived, p.6] |
| other long-term liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL LIABILITIES (Statement of financial position) | 10,981,156 [extracted, p.6] | 9,841,897 [extracted, p.6] | 11,611,492 [extracted, p.6] |
| net assets without donor restrictions (Statement of financial position) | 34,890,954 [derived, p.6] | 39,870,350 [derived, p.6] | 38,258,494 [derived, p.6] |
| net assets with donor restrictions (Statement of financial position) | 1,394,835 [derived, p.6] | 3,106,757 [derived, p.6] | 6,616,327 [derived, p.6] |
| TOTAL NET ASSETS (Statement of financial position) | 36,285,789 [extracted, p.6] | 42,977,107 [extracted, p.6] | 44,874,821 [extracted, p.6] |
| patient service revenue, net (Statement of activities) | 29,537,724 [derived, p.7] | 29,323,415 [derived, p.7] | 22,822,454 [derived, p.7] |
| pharmacy and 340B revenue (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| federal grants (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other grants and contracts (Statement of activities) | 23,984,892 [derived, p.7] | 20,411,503 [derived, p.7] | 24,752,655 [derived, p.7] |
| contributions (Statement of activities) | 683,000 [derived, p.7] | 1,108,870 [derived, p.7] | 321,991 [derived, p.7] |
| other revenue (Statement of activities) | 9,515,371 [derived, p.7] | 12,291,545 [derived, p.7] | 13,487,230 [derived, p.7] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 63,720,987 [extracted, p.7] | 63,135,333 [extracted, p.7] | 61,384,330 [extracted, p.7] |
| salaries and benefits (Statement of activities) | 46,839,849 [derived, p.7] | 42,786,574 [derived, p.7] | 38,000,539 [derived, p.7] |
| supplies and pharmaceuticals (Statement of activities) | 5,144,699 [derived, p.7] | 4,330,638 [derived, p.7] | 3,946,980 [derived, p.7] |
| purchased and professional services (Statement of activities) | 6,203,364 [derived, p.7] | 5,361,626 [derived, p.7] | 6,211,243 [derived, p.7] |
| occupancy (Statement of activities) | 5,153,772 [derived, p.7] | 3,837,205 [derived, p.7] | 3,377,982 [derived, p.7] |
| depreciation and amortization (Statement of activities) | 1,808,320 [derived, p.7] | 1,678,218 [derived, p.7] | 1,447,616 [derived, p.7] |
| interest (Statement of activities) | 23,228 [derived, p.7] | 36,608 [derived, p.7] | 62,016 [derived, p.7] |
| other expenses (Statement of activities) | 3,527,151 [derived, p.7] | 3,492,608 [derived, p.7] | 3,167,720 [derived, p.7] |
| TOTAL EXPENSES (Statement of activities) | 68,700,383 [extracted, p.7] | 61,523,477 [extracted, p.7] | 56,214,096 [extracted, p.7] |
| OPERATING RESULT (Statement of activities) | -4,979,396 [extracted, p.7] | 1,611,856 [extracted, p.7] | 5,170,234 [extracted, p.7] |
| non-operating and other changes (Statement of activities) | -1,711,922 [derived, p.7] | -3,509,570 [derived, p.7] | 4,371,920 [derived, p.7] |
| CHANGE IN NET ASSETS (Statement of activities) | -6,691,318 [extracted, p.7] | -1,897,714 [extracted, p.7] | 9,542,154 [extracted, p.7] |
| net assets, beginning (Statement of activities) | 42,977,107 [extracted, p.7] | 44,874,821 [extracted, p.7] | 35,332,667 [extracted, p.7] |
| net assets, end (Statement of activities) | 36,285,789 [extracted, p.7] | 42,977,107 [extracted, p.7] | 44,874,821 [extracted, p.7] |

| Ratio | FY ending 2025-05-31 | FY ending 2024-05-31 | FY ending 2023-05-31 |
|---|---:|---:|---:|
| Days cash on hand | 61 days [plausible] | 98 days [plausible] | 103 days [plausible] |
| Current ratio | 2.69x [plausible] | 4.04x [plausible] | 3.83x [plausible] |
| Operating margin | -7.8% [plausible] | 2.6% [plausible] | 8.4% [plausible] |
| Total margin | -10.5% [plausible] | -3.0% [plausible] | 15.5% [plausible] |
| Patient revenue share | 46.4% [plausible] | 46.4% [plausible] | 37.2% [plausible] |
| Grant dependency | absent [not computed] | absent [not computed] | absent [not computed] |
| Salaries share | 68.2% [plausible] | 69.5% [plausible] | 67.6% [plausible] |
| Days in patient receivables | 36 days [plausible] | 59 days [plausible] | 40 days [plausible] |
| Debt to net assets | 0.16x [plausible] | 0.10x [plausible] | 0.12x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (Nevada Health Centers, Inc.; FAC-11 template snapshot, SRC-FAC-001); the organization match is matched by name.

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Nevada Health Centers, Inc.", https://astrelis.co/providers/health_center/291802, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.